Back to CRL
Boston Trust Walden Corp → CRL
Boston Trust Walden Corp CRL Position History
Charles River Laboratories International, Inc. • Healthcare
Quarters held
8
Latest value
$53.3M
Q3 2026
Peak value
$53.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $44.8M |
| Q4 2025 | $16M |
| Q1 2026 | $35.8M |
| Q1 2026 | $13.5M |
| Q2 2026 | $46.5M |
| Q2 2026 | $19M |
| Q3 2026 | $20.9M |
| Q3 2026 | $53.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $53.3M | 180.5K | — | — |
| Q3 2026 | $20.9M | 70.9K | — | — |
| Q2 2026 | $19M | 83.9K | — | — |
| Q2 2026 | $46.5M | 205.1K | — | — |
| Q1 2026 | $13.5M | 78.1K | — | — |
| Q1 2026 | $35.8M | 207.4K | — | — |
| Q4 2025 | $16M | 80.2K | — | — |
| Q4 2025 | $44.8M | 224.7K | — | — |
Other funds holding CRL
$508.3M
$422.8M
$422.8M
$371.4M
$362.1M
$334.6M
$328.4M
$323.2M